These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9187917)

  • 21. Special Issue on HIV.
    Laurent GJ
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1665. PubMed ID: 15183335
    [No Abstract]   [Full Text] [Related]  

  • 22. Insights into immunopathogenic mechanisms of HIV infection: high levels of immune activation and HIV fitness.
    Feller L; Khammissa RA; Wood NH; Meyerov R; Lemmer J
    SADJ; 2008 Nov; 63(10):552, 554, 556-7. PubMed ID: 19322966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural killer cell inhibits human immunodeficiency virus replication in chronically infected immune cells.
    Zhang T; Li Y; Wang YJ; Wang X; Young M; Douglas SD; Ho WZ
    Antiviral Res; 2007 Feb; 73(2):132-9. PubMed ID: 16997390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The trap: professional exposure to human immunodeficiency virus antibody negative blood with high viral load.
    Giulieri S; Schiffer V; Yerly S; Burgisser P; Hirschel B; Cavassini M
    Arch Intern Med; 2007 Dec; 167(22):2524-6. PubMed ID: 18071177
    [No Abstract]   [Full Text] [Related]  

  • 25. The dynamics of CD4+ T-cell depletion in HIV disease.
    McCune JM
    Nature; 2001 Apr; 410(6831):974-9. PubMed ID: 11309627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of complement in the control of HIV dynamics and pathogenesis.
    Stoiber H; Speth C; Dierich MP
    Vaccine; 2003 Jun; 21 Suppl 2():S77-82. PubMed ID: 12763687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of antibodies to human immunodeficiency virus (HIV) that recognize conformational epitopes of glycoproteins 160 and 41 often allows for early diagnosis of HIV infection.
    Chen J; Wang L; Chen JJ; Sahu GK; Tyring S; Ramsey K; Indrikovs AJ; Petersen JR; Paar D; Cloyd MW
    J Infect Dis; 2002 Aug; 186(3):321-31. PubMed ID: 12134228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation and control of the human immunodeficiency virus.
    Stengel RF
    Math Biosci; 2008 Jun; 213(2):93-102. PubMed ID: 18439629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV pathogenesis: the first cut is the deepest.
    Picker LJ; Watkins DI
    Nat Immunol; 2005 May; 6(5):430-2. PubMed ID: 15843796
    [No Abstract]   [Full Text] [Related]  

  • 30. Hide, shield and strike back: how HIV-infected cells avoid immune eradication.
    Peterlin BM; Trono D
    Nat Rev Immunol; 2003 Feb; 3(2):97-107. PubMed ID: 12563294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Field recognition of pathogen and HIV self.
    Kerven R
    Med Hypotheses; 2000 Mar; 54(3):381-4. PubMed ID: 10783469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and immune correlates of the HIV infection and vaccine-induced immunity. Foreword.
    Füst G
    Vaccine; 2008 Jun; 26(24):2949-50. PubMed ID: 18321613
    [No Abstract]   [Full Text] [Related]  

  • 33. Challenges and opportunities for development of an AIDS vaccine.
    Nabel GJ
    Nature; 2001 Apr; 410(6831):1002-7. PubMed ID: 11309631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of HIV and SIV neutralization sensitivity by DC-SIGN and mannose-binding lectin.
    Marzi A; Mitchell DA; Chaipan C; Fisch T; Doms RW; Carrington M; Desrosiers RC; Pöhlmann S
    Virology; 2007 Nov; 368(2):322-30. PubMed ID: 17659761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral immunity to HIV-1: neutralization and beyond.
    Huber M; Trkola A
    J Intern Med; 2007 Jul; 262(1):5-25. PubMed ID: 17598812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemokine receptors: their role in human immunodeficiency virus (HIV) pathogenicity and resistance to HIV infections].
    Us D
    Mikrobiyol Bul; 2003 Jan; 37(1):75-87. PubMed ID: 12838682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.
    Deeks SG; Walker BD
    Immunity; 2007 Sep; 27(3):406-16. PubMed ID: 17892849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The complement system].
    Colomb M; Tournoud A
    Pediatrie; 1980 Jun; 35(4):285-92. PubMed ID: 7465295
    [No Abstract]   [Full Text] [Related]  

  • 39. [Complement in 1994: clinical importance and perspectives].
    Binet I; Schifferli J
    Praxis (Bern 1994); 1995 Apr; 84(14):399-401. PubMed ID: 7724950
    [No Abstract]   [Full Text] [Related]  

  • 40. Complement enhancement of HIV infection is mediated by complement receptors.
    Thieblemont N; Delibrias C; Fischer E; Weiss L; Kazatchkine MD; Haeffner-Cavaillon N
    Immunopharmacology; 1993; 25(2):87-93. PubMed ID: 8500986
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.